GlassScriptPhysician profile
Mary Clarke
NPI 1194839589
$628.28
in general payments reported to CMS, 2019-2025
16 companies · $214 in 2025
The $214 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $238 · 2020: $50.68 · 2021: $36.51 · 2022: $38.80 · 2023: $31.02 · 2024: $19.04 · 2025: $214.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $239 · Education: $25.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $238.55 |
| Education | $25.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $148.39 | 2019-2025 | Evenity, Prolia |
| Amarin Pharma, INC. | $94.82 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $65.52 | 2019-2020 | |
| Astellas Pharma US INC | $51.75 | 2019 | |
| Merck Sharp & Dohme LLC | $44.74 | 2024-2025 | Enflonsia, Gardasil, Gardasil 9 |
| Glaxosmithkline, LLC. | $42.61 | 2019-2023 | Trelegy Ellipta, Shingrix |
| Abbvie INC. | $34.45 | 2023-2025 | Viberzi, Linzess |
| Lilly USA, LLC | $26.51 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $24.22 | 2019-2022 | |
| Inspire Medical Systems, INC. | $17.41 | 2025 | Inspire |
| Ferring Pharmaceuticals INC. | $16.25 | 2025 | Rebyota |
| Novo Nordisk INC | $15.49 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $11.89 | 2019 | |
| Hologic Sales and Service, LLC | $11.72 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $11.62 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $10.89 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Clarke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.